Register using the form or link, available below! Find your panellists further down.

Summary & Learning Objectives:

AI presents both a massive opportunity for pathology, and a considerable change for labs and pathologists still reliant on microscope-based workflows. Join Dr. Piotr Borkowski, Medical Director of Anatomic Pathology at Quest Diagnostics as he offers a first-hand perspective on working with Digital Pathology and AI day-to-day, the impact it has on workflows, pathologists and their performance, and what it potentially means for patients.

Together with Proscia and Ibex Medical Analytics, this webinar will delve into the value of an integrated AI and platform solution through real-world experience. Dr. Borkowski will guide webinar attendees through the routine diagnostic workflows of several different cases to show how an AI-enabled digital pathology improves speed, accuracy, and the pathologist user experience.

You’ll walk away from this webinar with a first-hand understanding of AI-enabled digital workflows, and learn:

• How deeply integrated AI-powered workflows drive lab efficiency, allowing pathologists to sign out cases as much as 58% faster using Concentriq® with Ibex AI in a recent study.
• That digital pathology is easy to use and learn, and improves the pathologists’ experience. Hear why pathologists are eager to adopt Proscia’s Concentriq with Ibex Prostate AI.
• Ibex AI is highly accurate in detecting cancer and other pathologies, and in alignment with the accuracy of the pathologists’ diagnoses.

Speaker Biographies:

Dr. Piotr Borkowski attended and graduated from the Medical University in Gdansk, Poland in 1990. He has over 25 years of experience in diagnostic tissue pathology, research, molecular diagnostics, and computerized image analysis. From 1990-1993 he took a postdoctoral research fellowship at the University of Maryland and the National Institutes of Health studying molecular aspects of growth factors in atherosclerosis and digital image processing and analysis. For his work on TGF-beta one gene expression and associated computerized analysis, Dr. Borkowski received the prestigious Stowell-Orbison Award.From 1993 to 1996 he was a resident in anatomic and clinical pathology, and the Chief Resident (1997) at Mount Sinai Medical Center, Miami Beach, Florida. While a resident, he was awarded a Cardiovascular Research Grant as a Primary Investigator and received scientific honors including the Klausner Award for Best Basic Research Paper (’94,’96) and the Sidney Israel Resident in Pathology Award (’97). From 1997- 2001, Dr. Borkowski worked in a hospital based private practice as a Staff Pathologist for St. Joseph Hospital in Port Charlotte, Florida and then Parkway Regional Medical Center, North Miami Beach, Florida. In 2001, Dr. Borkowski joined Quest Diagnostics as a Senior Staff Pathologist specializing in Uropathology, Gastrointestinal pathology, and Clinical Informatics. He currently serves as a Sr Managing and Medical Director for Quest/Ameripath Tampa and Central Florida Business Unit. Dr. Borkowski also serves as the Director of the Center of Excellence for Digital and AI-Empowered Pathology of Quest Diagnostics. He also serves on the board of Florida Society of Pathologists, the CAP Digital and Computational Pathology Committee and on the editorial board of AI in Precision Oncology journal. He also co- chairs Digital Pathology and Artificial Intelligence committee of Quest Diagnostics. Dr. Borkowski is board certified in Anatomic Pathology, Clinical Pathology and Clinical Informatics by the American Board of Pathology.

Stephan Fromme, Head of Strategic Alliances at Proscia, has been in the digital pathology industry for more than 10 years. In his current role, Stephan is responsible for driving Proscia’s global partnerships and the Proscia Ready program, working closely with laboratories, healthcare institutions, and the industry. Prior to joining Proscia, he contributed to development and adoption of digital pathology solutions at AstraZeneca’s Computational Pathology division and Philips Digital Pathology.

Stuart Shand is Chief Commercial Officer at Ibex Medical Analytics, where he leads global Sales, Customer Success and Marketing. Prior to joining Ibex, Stuart led Commercial teams at Philips Digital Pathology. He received his Bachelor’s degree in Applied Biology from University of East Anglia, and his Masters in Business Administration from the University of Pittsburgh.